EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In silico molecular docking of quercetin as anti-colorectal cancer agents by inhibiting LT4AH

Made Agus Widiana Saputra, Anak Agung Istri Rani Mahaswari, Ni Ketut Sri Anggreni, Wahyu Nadi Eka Putri, Ni Putu Linda Laksmiani

Pharmacy Reports · 2021

DOI: 10.51511/pr.16 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacy Reports, 2021. Verfasst von Made Agus Widiana Saputra und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Kementerian Riset, Teknologi dan Pendidikan Tinggi,Kementerian Riset, Teknologi dan Pendidikan Tinggi.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer is a malignant neoplasm originating from the colon or rectum. Overexpression of leukotriene A4 hydrolase (LTA4H) increases the growth of HCT116 colon cancer cells, therefore, this enzyme becomes an attractive target for commercial drug bestatin. Meanwhile, quercetin is a member of flavonoids possessing a wide variety of anticancer. This study aimed to determine the potential of quercetin as anti-colorectal cancer by inhibiting LTA4H through in silico molecular docking. The docking process involved optimizing quercetin structure, preparing LTA4H protein (PDB ID: 3U9W), validating the molecular docking method, and docking quercetin and bestatin on LTA4H. The binding energy of quercetin to LTA4H was -9.57 kcal/mol, while 28P native ligand and bestatin yielded -10.22 kcal/mol and -9.10 kcal/mol, respectively. Based on the binding energy value, quercetin has a potential inhibitory against the LTA4H.

Förderung

  • Kementerian Riset, Teknologi dan Pendidikan Tinggi,Kementerian Riset, Teknologi dan Pendidikan Tinggi

Zitieren

APA

Saputra, M. A. W., Mahaswari, A. A. I. R., Anggreni, N. K. S., Putri, W. N. E., & Laksmiani, N. P. L. (2021). In silico molecular docking of quercetin as anti-colorectal cancer agents by inhibiting LT4AH. Pharmacy Reports. https://doi.org/10.51511/pr.16

Vancouver

Saputra MAW, Mahaswari AAIR, Anggreni NKS, Putri WNE, Laksmiani NPL. In silico molecular docking of quercetin as anti-colorectal cancer agents by inhibiting LT4AH. Pharmacy Reports. 2021. doi:10.51511/pr.16

BibTeX
@article{Saputra2021,
  author = {Saputra, Made Agus Widiana and Mahaswari, Anak Agung Istri Rani and Anggreni, Ni Ketut Sri and Putri, Wahyu Nadi Eka and Laksmiani, Ni Putu Linda},
  title = {In silico molecular docking of quercetin as anti-colorectal cancer agents by inhibiting LT4AH},
  journal = {Pharmacy Reports},
  year = {2021},
  doi = {10.51511/pr.16}
}
Kostenlos starten →